SCHEMBL9908803

SCHEMBL9908803

C=CC(=O)OC(C)Oc1ccc2cc(C(=O)Oc3ccc(OC(=O)c4ccc5cc(OC(C)OC(=O)C=C)ccc5c4)c(C(=O)OC)c3)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HGFAC Q04756 1/20 0.43
KMT2A Q03164 8/20 0.40
MAPT P10636 4/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 5/20 0.37
HSD17B10 Q99714 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F12 P00748 1/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CYSLTR2 Q9NS75 1/20 0.34
CYSLTR1 Q9Y271 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908797 0.91 MAPT (0.49) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9908806 0.87 HGFAC (0.41) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9908805 0.85 HGFAC (0.39) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9908804 0.84 HGFAC (0.38) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9906562 0.82 HGFAC (0.43) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL13283228 0.81 KMT2A (0.40) HGFACKMT2AMAPTMEN1SLC6A3
SCHEMBL9906516 0.81 HGFAC (0.42) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL14981341 0.81 KMT2A (0.45) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9906511 0.80 HGFAC (0.41) HGFACKMT2AMAPTKDM4EPOLB
SCHEMBL9906509 0.80 HGFAC (0.41) HGFACKMT2AMAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8197710-B2 Polymerizable compound and polymerizable composition ADEKA CORPORATION (JP) 2012-06-12 US disclosed
US-20100294990-A1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100294990-A1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION PYM1, SCO2, ZYX HGFAC 3700/4885KMT2A 1150/4885MAPT 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.